Published: Jun, 2017

The frontrunners in the global active pharmaceutical ingredients (API) market in 2015, according to a study by Transparency Market Research (TMR), were North China Pharmaceutical Group Corp. (NCPC), Zhejiang Medicine Co. Ltd and Zhejiang NHU Co. Ltd., Teva Pharmaceutical Industries Ltd., and Northeast Pharmaceutical Group Co. Ltd. Key players are banking on strategic mergers and acquisitions to expand their presence across different geographies. Besides this, players are also focusing towards research and development activities to deliver result-oriented drugs. “The global API market features high entry and exit barriers owing to the large capital investment requirement for set-up,” says TMR’s lead analyst.

The opportunity in the global active pharmaceutical market was pegged at US$134.7 bn in 2015 and is poised to rise to US$219.60 bn by 2023, progressing at a CAGR of 6.3% between 2015 and 2023.


North America to Lead Revenue Generation through 2023

On the basis of therapeutic area, the global API market will be dominated by cardiovascular disorders throughout the forecast period.  The segment is also expected to expand at a significant CAGR of 6.63% during the same period. Geographically, North America will be at the forefront of growth in terms of revenue until 2023. The domicile of some pharmaceutical giants and the advent of biosimilars is providing a competitive edge to North America over other regions. Emerging countries such as China, India, and South Korea will offer ample of lucrative growth opportunities to market players.

Rising Penetration of Information Technology in Healthcare Sector to Bode Well for Growth of API Market

With exponentially rising demand for drugs, the global API market is expected to follow a notable growth trajectory during the forecast period. “Considering the rapidly growing global population, technological advancements, and widening pool of patients suffering from chronic diseases, the pace of development of drugs is likely to increase by leaps and bounds,” says a TMR analyst. The rising geriatric population worldwide is also escalating the demand for various types of drugs, which in turn working in favor of the global market.

Moreover, the improving access to healthcare in emerging countries coupled with the increasing penetration of information and communication technology in the healthcare sector is positively impacting the growth of the market. In addition, the increasing healthcare budgets in both developed and developing countries are also triggering the sales of API. Besides this, the increasing efforts by Indian API manufacturers to comply with the U.S. FDA norms are also stoking the growth of the overall market.

Empowering Presence of Generic Drugs to Inhibit Adoption of API

The burgeoning sales of generic drugs are acting as a major bottleneck in the development of the global API market. The patent expiry along with the shortage of blockbuster drugs, poor accessibility in remote areas of several emerging countries, and unaffordability are fuelling the consumption of generic drugs. However, several government organizations are taking measures to mitigate this issue. The European Union (EU) are setting up manufacturing facilities that not only help in improving the quality of the drugs sold in the market, but also in ensuring the sales of government-approved and quality-checked scientifically-developed drugs.

The above data has been derived from a TMR report, titled “Active Pharmaceutical Ingredients (API) Market (Manufacturing Process - Captive Manufacturing and Contract Manufacturing; API Type - Synthetic Chemical and Biological; Drug Type - Branded, Generic, and OTC; Therapeutic Area - Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, and NSAIDs) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.”

The global active pharmaceutical ingredients market is segmented as follows:

Global Active Pharmaceutical Ingredients Market, by Manufacturing Process

  • Captive Manufacturing
  • Contract Manufacturing

Global Active Pharmaceutical Ingredients Market, by API Type

  • Synthetic Chemical API
  • Biological API

Global Active Pharmaceutical Ingredients Market, by Drug Type

  • Branded Prescription Drugs
  • Generic Prescription Drugs
  • OTC Prescription Drugs

Global Active Pharmaceutical Ingredients Market, by Therapeutic Area

  • Cardiovascular Disorders
  • Metabolic Disorders
  • Neurological Disorders
  • Oncology
  • Musculoskeletal Disorders
  • NSAIDs
  • Other Therapeutics Uses

Global Active Pharmaceutical Ingredients Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia Pacific
  • Rest of the World (RoW)

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453